Serum Alkaline Phosphatase and Phosphate and Risk of Mortality and Hospitalization
Overview
Authors
Affiliations
Background And Objectives: Elevated alkaline phosphatase (AlkPhos) and phosphate levels are associated with cardiovascular morbidity and mortality in patients receiving dialysis. A retrospective cohort study was conducted to test these associations in outpatients with an estimated GFR > or =60 ml/min/1.73 m(2).
Design, Setting, Participants, & Measurements: Patients with serum AlkPhos and phosphate levels measured between 2000 and 2002 (n = 10,743) at Montefiore Medical Center (MMC) clinics were followed through September 11, 2008 (median 6.8 years). Mortality data were obtained via Social Security Administration records (n = 949 deaths). Hospitalization data were obtained from MMC records.
Results: The mean age was 51 years, 64% were women, 22% were white, 26% were non-Hispanic black, 16% were Hispanic, 13% had a diagnosis of hypertension, 9% had diabetes mellitus, and 8% had cardiovascular disease at baseline. AlkPhos and phosphate were independently associated with mortality and cardiovascular-related hospitalization after multivariable adjustment. Comparing patients in the highest (> or =104 U/L) versus lowest quartile of AlkPhos (< or =66 U/L), the adjusted hazard ratio (HR) for mortality was 1.65 (P trend across quartiles <0.001). For the highest compared with the lowest quartile of serum phosphate (> or =3.8 mg/dl versus < or =3.0 mg/dl), the adjusted HR for mortality was 1.29 (P trend across quartiles = 0.008). High AlkPhos but not phosphate levels were also associated with all-cause, infection-related, and fracture-related hospitalization.
Conclusions: Higher levels of serum AlkPhos and phosphate were associated with increased mortality and cardiovascular-related hospitalization in an inner-city clinic population. Further studies are needed to elucidate mechanisms underlying these associations.
Meng H, Guo L, Pan Y, Kong B, Shuai W, Huang H Heliyon. 2024; 10(21):e38730.
PMID: 39524803 PMC: 11544070. DOI: 10.1016/j.heliyon.2024.e38730.
Sensors in Bone: Technologies, Applications, and Future Directions.
Anwar A, Kaur T, Chaugule S, Yang Y, Mago A, Shim J Sensors (Basel). 2024; 24(19).
PMID: 39409211 PMC: 11478373. DOI: 10.3390/s24196172.
Mthana M, Mthiyane D Trop Anim Health Prod. 2024; 56(8):310.
PMID: 39352513 PMC: 11445329. DOI: 10.1007/s11250-024-04120-w.
Torrijo-Belanche C, Moreno-Franco B, Munoz-Cabrejas A, Calvo-Galiano N, Casasnovas J, Sayon-Orea C Nutrients. 2024; 16(11).
PMID: 38892532 PMC: 11174514. DOI: 10.3390/nu16111599.
Yamamoto S, Jorgensen H, Zhao J, Karaboyas A, Komaba H, Vervloet M Kidney Int Rep. 2024; 9(4):863-876.
PMID: 38765600 PMC: 11101738. DOI: 10.1016/j.ekir.2024.01.002.